Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma

Oral Oncology

Volumn 45, Issue 3, 2009, Pages 225-233

  Camisasca, Danielle Resende ^a   Honorato, Júlia ^a   Bernardo, Vagner ^a   da Silva, Licínio Esmeraldo ^a   da Fonseca, Eliene Carvalho ^a   de Faria, Paulo Antônio Silvestre ^b   Dias, Fernando Luiz ^b   Lourenço, Simone de Queiroz Chaves ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Bcl 2 associated X protein; Bcl X protein; C Bcl 2 proteins; Immunohistochemistry; Mouth neoplasms; Prognosis; Squamous cell carcinoma; Survival analysis

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; OVERALL SURVIVAL; PERINEURIUM; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TONGUE TUMOR; TUMOR DIFFERENTIATION; BIOSYNTHESIS; BRAZIL; EPIDEMIOLOGY; METABOLISM; MIDDLE AGED; MORTALITY; MOUTH; MOUTH TUMOR; PATHOLOGY; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BRAZIL; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH FLOOR; MOUTH NEOPLASMS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL ANALYSIS; TONGUE NEOPLASMS;

EID: 60649084743     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.05.021     Document Type: Article

References (29)

1. Stewart B.W., and Kleihues P. World cancer report (2003), IARC Press, Lyon. http://www.iarc.fr/press Available from: IARC.
2. Brazil, Ministry-of-Health. Estimate 2008: Brazilian cancer incidence. CONPREV/INCA, editor. Rio de Janeiro: INCA (NCI); 2007. Available from: INCA. .
3. Patel S.G., and Shah J.P. TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 55 4 (2005) 242-258 quiz 61-2, 64
4. Bettendorf O., Piffko J., and Bankfalvi A. Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy?. Oral Oncol 40 2 (2004) 110-119
5. Barnes L., Eveson J.W., Reichert P., and Sidransky D. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours (2005), IARC Press, Lyon
6. Brandwein-Gensler M., Teixeira M.S., Lewis C.M., Lee B., Rolnitzky L., Hille J.J., et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 29 2 (2005) 167-178
7. Oltvai Z.N., Milliman C.L., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 4 (1993) 609-619
8. Fiebig A.A., Zhu W., Hollerbach C., Leber B., and Andrews D.W. Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line. BMC Cancer 6 (2006) 213
9. Al-Rajhi N., Khafaga Y., El-Husseiny J., Saleem M., Mourad W., Al-Otieschan A., et al. Early stage carcinoma of oral tongue: prognostic factors for local control and survival. Oral Oncol 36 6 (2000) 508-514
10. Woolgar J.A. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol 42 3 (2006) 229-239
11. Woolgar J.A. Pathology of the N0 neck. Br J Oral Maxillofac Surg 37 3 (1999) 205-209
12. Jing J., Li L., He W., and Sun G. Prognostic predictors of squamous cell carcinoma of the buccal mucosa with negative surgical margins. J Oral Maxillofac Surg 64 6 (2006) 896-901
13. Kane S.V., Gupta M., Kakade A.C., and D'Cruz A. Depth of invasion is the most significant histological predictor of subclinical cervical lymph node metastasis in early squamous carcinomas of the oral cavity. Eur J Surg Oncol 32 7 (2006) 795-803
14. Hockenbery D.M., Zutter M., Hickey W., Nahm M., and Korsmeyer S.J. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88 16 (1991) 6961-6965
15. Krajewski S., Krajewska M., Shabaik A., Wang H.G., Irie S., Fong L., et al. Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res 54 21 (1994) 5501-5507
16. Krajewski S., Krajewska M., Shabaik A., Miyashita T., Wang H.G., and Reed J.C. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 145 6 (1994) 1323-1336
17. Casado S., Forteza J., Dominguez S., Abad M.T., Perez I., Intxaurbe I., et al. Predictive value of P53, BCL-2, and BAX in advanced head and neck carcinoma. Am J Clin Oncol 25 6 (2002) 588-590
18. Sampaio-Goes F.C., Oliveira D.T., Dorta R.G., Nonogaki S., Landman G., Nishimoto I.N., et al. Expression of PCNA, p53, Bax, and Bcl-X in oral poorly differentiated and basaloid squamous cell carcinoma: Relationships with prognosis. Head Neck 27 11 (2005) 982-989
19. Teni T., Pawar S., Sanghvi V., and Saranath D. Expression of bcl-2 and bax in chewing tobacco-induced oral cancers and oral lesions from India. Pathol Oncol Res 8 2 (2002) 109-114
20. Veneroni S., Silvestrini R., Costa A., Salvatori P., Faranda A., and Molinari R. Biological indicators of survival in patients treated by surgery for squamous cell carcinoma of the oral cavity and oropharynx. Oral Oncol 33 6 (1997) 408-413
21. Xie X., Clausen O.P., De Angelis P., and Boysen M. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer 86 6 (1999) 913-920
22. Wilson G.D., Saunders M.I., Dische S., Richman P.I., Daley F.M., and Bentzen S.M. Bcl-2 expression in head and neck cancer: an enigmatic prognostic marker. Int J Radiat Oncol Biol Phys 49 2 (2001) 435-441
23. Pena J.C., Thompson C.B., Recant W., Vokes E.E., and Rudin C.M. Bcl-xL and Bcl-2 expression in squamous cell carcinoma of the head and neck. Cancer 85 1 (1999) 164-170
24. Lo Muzio L., Falaschini S., Farina A., Rubini C., Pezzetti F., Campisi G., et al. Bcl-2 as prognostic factor in head and neck squamous cell carcinoma. Oncol Res 15 5 (2005) 249-255
25. de Vicente J.C., Olay S., Lequerica-Fernandez P., Sanchez-Mayoral J., Junquera L.M., and Fresno M.F. Expression of Bcl-2 but not Bax has a prognostic significance in tongue carcinoma. J Oral Pathol Med 35 3 (2006) 140-145
26. Popovic B., Jekic B., Novakovic I., Lukovic L.J., Tepavcevic Z., Jurisic V., et al. Bcl-2 expression in oral squamous cell carcinoma. Ann NY Acad Sci 1095 1 (2007) 19-25
27. Cheng E.H., Kirsch D.G., Clem R.J., Ravi R., Kastan M.B., Bedi A., et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278 5345 (1997) 1966-1968
28. Loro L.L., Johannessen A.C., and Vintermyr O.K. Loss of BCL-2 in the progression of oral cancer is not attributable to mutations. J Clin Pathol 58 11 (2005) 1157-1162
29. Chen Y., Kayano T., and Takagi M. Dysregulated expression of bcl-2 and bax in oral carcinomas: evidence of post-transcriptional control. J Oral Pathol Med 29 2 (2000) 63-69